Wird geladen...
Advances in Alzheimer’s Disease Drug Development
Alzheimer’s disease (AD) is the foremost cause of dementia worldwide. Clinically, AD manifests as progressive memory impairment followed by a gradual decline in other cognitive abilities leading to complete functional dependency. Recent biomarker studies indicate that AD is characterized by a long a...
Gespeichert in:
| Veröffentlicht in: | BMC Med |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4373002/ https://ncbi.nlm.nih.gov/pubmed/25857341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-015-0297-4 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|